Citation Impact
Citing Papers
Endogenous Markers of Two Separate Hypoxia Response Pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) Are Associated With Radiotherapy Failure in Head and Neck Cancer Patients Recruited in the CHART Randomized Trial
2006
The Human Tim/Tipin Complex Coordinates an Intra-S Checkpoint Response to UV That Slows Replication Fork Displacement
2007 StandoutNobel
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Theoretical Simulation of Oxygen Transport to Tumors by Three-Dimensional Networks of Microvessels
1998
Why do cancers have high aerobic glycolysis?
2004 Standout
Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer – report on 3-year tumour control and normal tissue toxicity
2000
EGFR Antagonists in Cancer Treatment
2008 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Applicability of animal tumor data to cancer therapy in humans
1988
Targeting hypoxia in cancer therapy
2011 Standout
Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: Long-term results of Phase III clinical trial
2006
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
Cell production rates in human tissues and tumours and their significance. Part II: clinical data
2000
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial
1997
Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer
1998
Altered fractionation and combined radio-chemotherapy approaches
2003
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
1999
A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer
1997
Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy
1995
Drug penetration in solid tumours
2006 Standout
A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer
1997
Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer
1999 Standout
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Accelerated Radiotherapy, Carbogen, and Nicotinamide (ARCON) in the Treatment of Advanced Bladder Cancer: Mature Results of a Phase II Nonrandomized Study
2008
Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma
2006
Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
1998 Standout
Patient-reported short-term and long-term physical and psychologic symptoms: results of the continuous hyperfractionated accelerated [correction of acclerated] radiotherapy (CHART) randomized trial in non-small-cell lung cancer. CHART Steering Committee.
1998
Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer
2012
Neurogenesis in the adult human hippocampus
1998 Standout
The molecular biology of head and neck cancer
2010 Standout
The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study
1993
Reproducibility of measurements of potential doubling time of tumour cells in the multicentre National Cancer Institute protocol T92-0045
1998
Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial
1997
The effect of treatment duration in the local control of cervix cancer
1992
One Century of Aryne Chemistry
2003 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
The rationale for continuous, hyperfractionated, accelerated radiotherapy (chart)
1990
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
2010 Standout
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
2001 StandoutNobel
High-tech in radiation oncology: should there be a ceiling?
2004
Variation of vascular density within and between tumors of the uterine cervix and its predictive value for radiotherapy
1989
Clinical Applications of Research on Angiogenesis
1995 Standout
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
2008 Standout
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial
2003
Targeting gene expression to hypoxic tumor cells
1997 StandoutNobel
Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial
2001
Bioreductively-activated prodrugs for targeting hypoxic tissues: Elimination of aspirin from 2-nitroimidazole derivatives
1999
Head and Neck Cancer
1993 Standout
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil–cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck
2004
Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome
1993
HIF-1α, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors
2002 StandoutNobel
The molecular landscape of head and neck cancer
2018 Standout
Noninvasive Assessment of Tumor Hypoxia with 99mTc Labeled Metronidazole
1999
Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo
1998
PET-CT–Based Auto-Contouring in Non–Small-Cell Lung Cancer Correlates With Pathology and Reduces Interobserver Variability in the Delineation of the Primary Tumor and Involved Nodal Volumes
2007
Double strand DNA cleavage with a binuclear iron complex
2006 StandoutNobel
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
DNA double labelling with IdUrd and CldUrd for spatial and temporal analysis of cell proliferation and DNA replication
1992
Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study.
1994
Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer
2004
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Head and Neck Cancer
2001 Standout
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Hypoxia imaging in brain tumors
2002
Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers
2000
Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part I: Historical perspectives, histochemical methods and cell kinetics
1995
Review The link between low-LET dose-response relations and the underlying kinetics of damage production/repair/misrepair
1997
Efficient DNA Cleavage with an Iron Complex without Added Reductant
2000 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Head and Neck Cancer
2020 Standout
Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy
1993
Recognition and Reaction of Metallointercalators with DNA
1999 Standout
Ligand Exchange and Spin State Equilibria of FeII(N4Py) and Related Complexes in Aqueous Media
2011 StandoutNobel
Oxidative Strand Scission of Nucleic Acids: Routes Initiated by Hydrogen Abstraction from the Sugar Moiety
1998
Oxidative Nucleobase Modifications Leading to Strand Scission
1998 Standout
Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part I: Historical perspectives, histochemical methods and cell kinetics
1995
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
2009 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
2012 Standout
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized Trial
2005
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck
2001
The linear-quadratic formula and progress in fractionated radiotherapy
1989 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know
2003 Standout
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
1997 Standout
Tumor hypoxia: its impact on cancer therapy
1987
Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma.
1996
Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: results of Eastern Cooperative Oncology Group 4593.
1998
Phase III Randomized Trial of Very Accelerated Radiation Therapy Compared With Conventional Radiation Therapy in Squamous Cell Head and Neck Cancer: A GORTEC Trial
2006
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Works of S Dische being referenced
Continuous, hyperfractionated, accelerated radiotherapy (CHART): an interim report upon late morbidity
1989
Overall treatment time and the conventional arm of the CHART trial in the radiotherapy of head and neck cancer
1999
A review of hypoxic cell radiosensitization
1991
What have we learnt from hyperbaric oxygen?
1991
Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: A competing risks analysis
2001
The long term outcome after radical radiotherapy for advanced head and neck cancer
1993
Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry
1988
The prognosis of Hodgkin's disease in older adults.
1991
Morbidity Related to Axillary Irradiation in the Treatment of Breast Cancer
2000
A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer
1998
Cell proliferation in human tumours measured by in-vivo labelling with bromodeoxyuridine
1988
Conventional vs modified fractionated radiotherapy. meta-analysis of radiotherapy in head & neck squamous cell carcinoma : a meta-analysis based on individual patient data
2002
Bcl-2 expression correlates with favourable outcome in head and neck cancer treated by accelerated radiotherapy.
1996
Hyperbaric oxygen: the Medical Research Council trials and their clinical significance
1978